Brussels, Belgium – 14 June 2021 – EuropaBio today announced that Novartis, the Swiss pharma company, has joined EuropaBio’s 25th Anniversary Celebration Programme as a sponsor.
Novartis, which itself celebrates 25 years since its creation through the merger of Ciba-Geigy and Sandoz in 1996, has the purpose of remaining medicine to improve and extend people’s lives, using innovative science and technology. As part of the anniversary, EuropaBio and Novartis will bring a focus to the journey of healthcare into sustainability as the world addresses climate change.
“The combination of our own 25th anniversary with that of EuropaBio is an excellent opportunity to show the very best of biotechnology and its positive impact on patients.” commented Andrew Topen, Head of European Public Affairs for Novartis.
During 2021, EuropaBio, together with its members and partners, will nominate the most impactful cross-sector developments from the last quarter-century and showcase how they have benefitted society and the environment. The year’s programme of celebratory events will end in December with a gala evening in Brussels and the presenting of the 2021 SME Award from EuropaBio.
Dr Claire Skentelbery, Director General of EuropaBio commented, “We are absolutely delighted to welcome Novartis to the anniversary as a sponsor. Their own dedication to progress in healthcare through biotechnology really shows how this technology holds the key for healthy citizens worldwide.”
Join in the EuropaBio anniversary celebrations for the whole of 2021 through our newsletter and visit the dedicated Anniversary website at www.europabio25.org.